Approval · Notice of Compliance 652 · 2002
LOXAPAC: Notice of Compliance 652
Issued March 11, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 652
- Date
- March 11, 2002
- Company
- Sabex Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antipsychotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOXAPAC | 02169991 | Marketed |
Medicinal ingredients
- LOXAPINE HCL 50 MG per ML